Amyloid, p-tau, neurofilament light, and α-synuclein cerebrospinal fluid biomarkers across Alzheimer's disease, dementia with Lewy bodies, and Parkinson's disease.
Rizzo M
,
Teunissen CE
,
Zetterberg H
,
Blennow K
,
Kollmorgen G
,
Krüger R
,
Fernandes SBG
,
Aarsland D
,
Borejko O
,
Hu M
,
Chokoshvili D
,
Vijverberg JEGB
,
Lemstra AW
,
Tijms BM
,
Petzold GC
,
Brockmann K
,
Gasser T
,
Frisoni GB
,
Hort J
,
Nedelska Z
,
Hopøy AC
,
Fladby T
,
Jessen F
,
Düzel E
,
Spottke A
,
Höglinger GU
,
Mutel S
,
Chevalier C
,
Krishnan R
,
Visser PJ
,
Vos SJB
,
Alzheimer's & dementia (Amsterdam, Netherlands) -
2026